CLPT
Income statement / Annual
Last year (2023), ClearPoint Neuro, Inc.'s total revenue was $23.96 M,
an increase of 16.56% from the previous year.
In 2023, ClearPoint Neuro, Inc.'s net income was -$22.09 M.
See ClearPoint Neuro, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$23.96 M
|
$20.55 M
|
$16.30 M
|
$12.83 M
|
$11.22 M
|
$7.35 M
|
$7.38 M
|
$5.75 M
|
$4.59 M
|
$3.60 M
|
| Cost of Revenue |
$10.34 M |
$7.02 M |
$5.01 M |
$3.71 M |
$3.83 M |
$2.43 M |
$2.90 M |
$2.64 M |
$1.99 M |
$1.93 M |
| Gross Profit |
$13.61 M |
$13.53 M |
$11.29 M |
$9.12 M |
$7.38 M |
$4.92 M |
$4.48 M |
$3.11 M |
$2.61 M |
$1.68 M |
| Gross Profit Ratio |
0.57 |
0.66 |
0.69 |
0.71 |
0.66 |
0.67 |
0.61 |
0.54 |
0.57 |
0.47 |
| Research and Development
Expenses |
$11.71 M
|
$10.89 M
|
$8.99 M
|
$4.69 M
|
$2.92 M
|
$2.31 M
|
$2.81 M
|
$2.63 M
|
$1.96 M
|
$3.30 M
|
| General & Administrative
Expenses |
$11.76 M
|
$9.61 M
|
$8.76 M
|
$5.27 M
|
$4.30 M
|
$4.33 M
|
$4.05 M
|
$4.19 M
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$12.60 M
|
$9.36 M
|
$6.92 M
|
$5.38 M
|
$4.76 M
|
$3.53 M
|
$3.96 M
|
$3.78 M
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$24.35 M
|
$18.97 M
|
$15.68 M
|
$10.65 M
|
$9.06 M
|
$7.86 M
|
$8.00 M
|
$7.97 M
|
$8.37 M
|
$8.04 M
|
| Other Expenses |
$0.00 |
-$22,000.00 |
-$63,000.00 |
$882,000.00 |
$9,054.00 |
$364.00 |
$16,682.00 |
$216,075.00 |
$230,875.00 |
$1.80 M |
| Operating Expenses |
$36.06 M |
$29.86 M |
$24.67 M |
$15.34 M |
$11.98 M |
$10.17 M |
$10.82 M |
$10.60 M |
$10.33 M |
$11.34 M |
| Cost And Expenses |
$46.40 M |
$36.88 M |
$29.67 M |
$19.05 M |
$15.81 M |
$12.60 M |
$13.72 M |
$13.24 M |
$12.32 M |
$13.26 M |
| Interest Income |
$386,000.00 |
$81,000.00 |
$973,000.00 |
$1.44 M |
$955,000.00 |
$0.00 |
$0.00 |
$8,807.00 |
$16,455.00 |
$11,617.00 |
| Interest Expense |
$0.00 |
$81,000.00 |
$973,000.00 |
$1.44 M |
$955,166.00 |
$980,383.00 |
$872,926.00 |
$1.06 M |
$1.26 M |
$1.01 M |
| Depreciation &
Amortization |
$1.46 M
|
$777,000.00
|
$692,000.00
|
$550,000.00
|
$250,560.00
|
$109,439.00
|
$116,454.00
|
$155,707.00
|
$211,946.00
|
$377,261.00
|
| EBITDA |
-$20.99 M
|
-$15.58 M
|
-$12.75 M
|
-$4.79 M
|
-$4.33 M
|
-$5.07 M
|
-$6.18 M
|
-$6.85 M
|
-$6.97 M
|
-$3.13 M
|
| EBITDA Ratio |
-0.88 |
-0.76 |
-0.78 |
-0.37 |
-0.39 |
-0.7 |
-0.84 |
-1.24 |
-1.58 |
-2.18 |
| Operating Income Ratio
|
-0.94
|
-0.79
|
-0.82
|
-0.48
|
-0.41
|
-0.71
|
-0.86
|
-1.3
|
-1.95
|
-1.48
|
| Total Other
Income/Expenses Net |
$357,000.00
|
-$103,000.00
|
-$1.04 M
|
-$562,000.00
|
-$945,790.00
|
-$915,701.00
|
-$831,516.00
|
-$581,157.00
|
$524,863.00
|
$795,890.00
|
| Income Before Tax |
-$22.09 M |
-$16.44 M |
-$14.41 M |
-$6.78 M |
-$5.54 M |
-$6.16 M |
-$7.17 M |
-$8.07 M |
-$8.45 M |
-$4.52 M |
| Income Before Tax Ratio
|
-0.92
|
-0.8
|
-0.88
|
-0.53
|
-0.49
|
-0.84
|
-0.97
|
-1.4
|
-1.84
|
-1.26
|
| Income Tax Expense |
$0.00 |
$103,000.00 |
$910,000.00 |
$2.33 M |
$964,220.00 |
$64,682.00 |
$889,608.00 |
$1.28 M |
$1.49 M |
$2.43 M |
| Net Income |
-$22.09 M |
-$16.54 M |
-$15.32 M |
-$9.11 M |
-$6.50 M |
-$6.16 M |
-$7.17 M |
-$8.07 M |
-$8.45 M |
-$4.52 M |
| Net Income Ratio |
-0.92 |
-0.8 |
-0.94 |
-0.71 |
-0.58 |
-0.84 |
-0.97 |
-1.4 |
-1.84 |
-1.26 |
| EPS |
-0.9 |
-0.68 |
-0.74 |
-0.57 |
-0.49 |
-0.56 |
-0.93 |
-2.93 |
-4.48 |
-3.06 |
| EPS Diluted |
-0.9 |
-0.68 |
-0.74 |
-0.57 |
-0.49 |
-0.56 |
-0.93 |
-2.93 |
-4.48 |
-3.06 |
| Weighted Average Shares
Out |
$24.61 M
|
$24.18 M
|
$20.73 M
|
$15.85 M
|
$13.16 M
|
$10.93 M
|
$7.74 M
|
$2.75 M
|
$1.88 M
|
$1.48 M
|
| Weighted Average Shares
Out Diluted |
$24.61 M
|
$24.18 M
|
$20.73 M
|
$15.85 M
|
$13.16 M
|
$10.93 M
|
$7.74 M
|
$2.75 M
|
$1.88 M
|
$1.48 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
